cervical cancer
Becton Dickinson's HPV assay was FDA-approved for use with clinician-collected samples in 2018 and received approval for sample self-collection in May.
Predica Diagnostics Developing Targeted Sequencing Test for Cervical Cancer Diagnosis, Screening
Premium
The test is based on targeted circular probe-based RNA next-generation sequencing (ciRNAseq), which enables a high degree of multiplexing and mutational analysis.
MGI Tech, Predica Diagnostics Partner to Develop RNA-Based Cancer Screening Tests
The companies will combine Predica’s proprietary circular probe-based RNA-seq technology with MGI’s DNBSeq platforms for early cancer detection.
Roche Molecular HPV Test Receives WHO Prequalification
The prequalification designations are for the test's use on the Cobas 5800 platform and for use with self-collected samples on the Cobas 5800, 6800, and 8800 instruments.
Aptamer Group Inks £465K Deal With Timser Group for Cervical Cancer Test Reagents
Aptamer Group will develop a set of its aptamer-based Optimer binders for Timser's blood-based cervical cancer biomarker panel.